Zai Lab (ZLAB) Tax Rate (2025 - 2026)
Zai Lab (ZLAB) posted Tax Rate of 2.9% for Q1 2026, down 152.93% sequentially from 5.49% in Q4 2025.
Analysis
Zai Lab (ZLAB) Tax Rate (2025 - 2026) Analysis & Trends
Zai Lab has reported Tax Rate for 2 years, with the latest figure at 2.9% in Q1 2026.
- Quarterly Tax Rate changed N/A year-over-year to 2.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.83% (changed N/A YoY) and the FY2025 annual result came in at 1.64%, changed N/A from the prior year.
- Tax Rate declined to 2.9% in Q1 2026 per ZLAB's latest filing, from 5.49% in the prior quarter.
- Over five years, Tax Rate peaked at 5.49% in Q4 2025 and troughed at 2.9% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 1.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97% |
| Mar 31, 2026 | -2.90% |
| Dec 31, 2025 | 5.49% |